Kettering University

Digital Commons @ Kettering University
Physics Grants

Physics

8-4-2014

Investigating Smart Magnetic Nanoparticles for
Hyperthermia Treatment of Cancer
Ronald J. Tackett
Kettering University, rtackett@kettering.edu

Prem P. Vaishnava
Kettering University, pvaishna@kettering.edu

Ronald E. Kumon
Kettering University, rkumon@kettering.edu

Corneliu Rablau
Kettering University, crablau@kettering.edu

Follow this and additional works at: https://digitalcommons.kettering.edu/physics_facultygrants
Part of the Physics Commons
Recommended Citation
Tackett, Ronald J.; Vaishnava, Prem P.; Kumon, Ronald E.; and Rablau, Corneliu, "Investigating Smart Magnetic Nanoparticles for
Hyperthermia Treatment of Cancer" (2014). Physics Grants. 5.
https://digitalcommons.kettering.edu/physics_facultygrants/5

This Article is brought to you for free and open access by the Physics at Digital Commons @ Kettering University. It has been accepted for inclusion in
Physics Grants by an authorized administrator of Digital Commons @ Kettering University. For more information, please contact
digitalcommons@kettering.edu.

Investigating Smart Magnetic Nanoparticles for Hyperthermia Treatment of Cancer
Co-Principal Investigators:
Ronald J. Tackett, Ph.D.
Assistant Professor, Department of Physics
Kettering University
Prem P. Vaishnava, Ph.D.
Professor, Department of Physics
Kettering University
Ronald E. Kumon, Ph.D.
Assistant Professor, Department of Physics
Kettering University
Corneliu Rablau
Associate Professor, Department of Physics
Kettering University

Proposal submitted for the 2014—2015 Faculty Research Fellowship
August 04, 2014

A. SPECIFIC AIMS
In recent years, the application of magnetic nanoparticles (MNPs) in magnetic fluid hyperthermia
(MFH) has emerged as a viable alternative to radiotherapy, chemotherapy, and surgery for the
treatment of a wide variety of cancerous tumors. The MFH procedure, which requires raising the
temperature of the tumor to 42 – 45o C, has become more prevalent in Europe and Asia as compared
to the rest of the world. Despite a number of ongoing phase III trials to use MHF clinically, it still
remains a mostly experimental method in the United States due to the possibility of necrosis of normal
tissue due to overheating. Therefore the search is on for a smart MNP system with the ability to
maintain a temperature in the desired range without the possibility of overheating.
The concept of MFH is based on the high heat-sensitivity of malignant neoplastic tissue when
compared to that of normal human cells. For local magnetic fluid hyperthermia, MNPs in a carrier fluid
are delivered to the tumor site via direct injection or targeted to the site through the use of tumor
specific antibodies. Once inside the tumor, the nanoparticles are exposed to an alternating magnetic
field which causes heating of the MNPs due to magnetic relaxation (both Néel and Brownian
mechanisms) as well as hysteretic losses. Such a rise in temperature is enough to kill cancer cells while
leaving healthy tissue unharmed.
Much research into MFH has centered on iron-oxide-based based materials due to their
ferrimagnetic nature and biocompatibility; however, one desirable property which these materials lack
is the ability to “self-control” the thermal characteristics of the hyperthermia treatment. During
treatment, heat conduction and energy absorption are extremely difficult to monitor in vivo which may
cause overheating that can damage normal human tissue. In some complex magnetic oxides the “turnoff” temperature for the ferrimagnetic behavior (referred to as the Curie temperature) can be
suppressed to coincide with the desired maximum MFH temperature. These smart materials, such as
La1-xSrxMnO3, are the subject of our proposed investigation.
Specific Aim #1: Synthesis of La1-xSrxMnO3 for use in MFH studies. We will prepare a series of
samples by varying x between 0.1 and 0.8 in La1-xSrxMnO3 to obtain materials with different Curie
temperatures in the range of 40˚C – 50˚C. This will provide MNPs to regulate the maximum
temperature reached during MFH treatments.
Specific Aim #2: Investigation of the structural characteristics of the synthesized samples.
The La1-xSrxMnO3 MNPs will be characterized by X-ray diffraction (XRD), scanning electron microscopy
(SEM) and transmission electron microscopy (TEM) for phase identification as well as the
determination of particle morphology.
Specific Aim #3: Investigation of the magnetic properties of the proposed nanoparticles
through the use of dc- and ac-magnetometry. In order to determine the Curie temperature and
magnetodynamics of the La1-xSrxMnO3 MNPs we will perform temperature-dependent magnetic
experiments using the magnetometer at Wayne State University.
Specific Aim #4: Investigation of the magnetic heating of an aqueous suspension of the
nanoparticles under an alternating magnetic field. These studies must be performed for a number of
reasons which include the determination of the temperature dependent specific absorption rate (SAR)

of the aqueous La1-xSrxMnO3 MNP solution as well as the “shut-off” characteristics of the smart MNPs
as they near their Curie temperature.
B. BACKGROUND AND SIGNIFICANCE
Magnetic hyperthermia has been widely considered as a possible non-invasive treatment for
cancerous solid tumors since its introduction in 1957 when Gilchrist et al [1] used 20—100 nm
particles of γ-Fe2O3 in conjunction with an alternation magnetic field in the MHz range to heat
various tissue samples. In broad terms, MFH involves the dispersion of magnetic nanoparticles
throughout a tumor site and the exposure of these nanoparticles to a small (~mT) time-varying
magnetic field in the RF range. The relaxation of the magnetic nanoparticles into the field causes
dispersion of heat due to various methods of energy loss (Néel relaxation, Brownian relaxation,
hysteretic losses, etc.). This heat is conducted to the nearby cancerous tissue whereby, if the
temperature can be maintained above
a threshold of 42˚C – 46˚C for a time of
not less than 30 minutes, the cancer
will be destroyed via necrosis,
coagulation and carbonization. The
most commonly used materials for this
treatment are mono-metallic oxides
such as γ-Fe2O3 and Fe3O4 (Figure 1)
because of their abundance and
biocompatibility.
In general, heat production via
magnetic materials in alternating
magnetic fields arises due to two
general classes of materials: multidomain ferro(ferri-)magnetic systems
and single-domain superparamagnetic
systems.
In the former, heat
production originates primarily through hysteretic power losses. For superparamagnetic
nanoparticles, heating is accomplished through losses as the particles’ superspins align with the
external field through the Néel mechanism (rotation of the magnetic moment within a fixed
particle) and Brownian motion (physical rotation of the particle with a fixed moment), the latter of
which can contribute to the dissipation of energy by means of friction [2]. Typically, MFH is
accomplished using superparamagnetic iron oxide nanoparticles (Fe3O4 and γ-Fe2O3) [3-7].
However, these materials lack the ability to self-control the maximum temperature reached by
MFH due to their high Curie temperatures. Perovskite manganites have been proposed as possible
materials in which the Curie temperature can be suppressed into the range between 42—38˚C by
doping with non-magnetic cations. These materials, of the form La1-xSrxMnO3 and La1-xAgxMnO3 [89], have been shown to have Curie temperatures in this desired range (achieved through the
replacement of lanthanum by strontium or silver ions in the perovskite A sites). We wish to study
these materials in order to confirm the optimized doping needed in order to achieve a Curie
temperature near 46˚C.

C. SUMMARY OF EXPERIMENTAL DESIGN AND METHODS
Synthesis of perovskite manganite nanoparticles. The synthesis of La1-xSrxMnO3 nanoparticles
will be accomplished via solid state reaction of La2O3, SrCO3 and MnO3 powders mixed in
appropriate stoichiometric quantities, pressed into pellets and heated to high temperatures (up to
1500˚C). The resulting powders will be milled until we have achieved the desired particle size (20—
100 nm diameters). A variety of different stoichiometric samples will be made in order to compare
the physical properties of each sample (we will vary the amount of strontium in the samples).
Structural and morphological characterization. Samples synthesized via the method above will
be analyzed through x-ray diffraction in order to confirm the perovskite nature of the materials in
addition to confirmation of particle size. In addition, scanning and transmission electron
microscopy will be used to further investigate the phase and morphology of the samples.
Magnetic characterization. Using a Quantum Design Model 6000 Physical Properties
Measurement system (at Wayne State University), we will investigate the ac- and dc- magnetic
properties of the synthesized samples. We will specifically look at the temperature-dependent
properties in order to determine the Curie temperature of the samples.
Analysis of the heating characteristics. The heating characteristics of each sample will be
measured using Kettering University’s Ambrell EASYHEAT system. Specifically, we are interested in
determining two main points: The specific absorption rate (SAR) of the sample as it heats from
room temperature, and the samples ability to hold a constant temperature in the range of 42—
46˚C while constantly being driven by the ac magnetic field. The SAR is defined to be the power
dissipated by a magnetic material subjected to an alternating magnetic field. For MFH, the SAR is
related to the specific heat of the solvent in which the magnetic nanoparticles are suspended, the
weight fraction of the magnetic element, and the slope of the temperature vs. time curve.
D. POTENTIAL SOURCES OF EXTERNAL FUNDING
The preliminary data obtained from this project presents itself well to solicitation of funds from
both the National Institutes of Health (NIH) and the National Science Foundation (NSF). For
example, the Biomaterials program (BMAT) within the NSF’s Division of Materials Research (DMR)
which supports fundamental research related to (1) biological materials, (2) biometric, bioinspired,
and bioenabled materials, (3) synthetic materials intended for applications in contact with
biological systems, and (4) the processes through which nature produces biological materials (taken
from www.nsf.gov) would be ideal sources of future external funding for this research.

E. BUDGET
We anticipate the following expenses for this project
Budgeted Item
Undergraduate Research Assistantships
Planetary Ball Mill (cost-share with startup funds – IGA 350134)
Materials and Lab Supplies
Publication Charges
TOTAL
F.
1.
2.
3.
4.
5.
6.
7.
8.
9.

Amount
$3,000.00
$1,500.00
$1,000.00
$500.00
$6,000.00
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